These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3002694)

  • 1. An investigation of the receptors involved in the coronary vasodilatory effect of adenosine analogues.
    Leung E; Johnston CI; Woodcock EA
    Clin Exp Pharmacol Physiol; 1985; 12(5):515-9. PubMed ID: 3002694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.
    Vials A; Burnstock G
    Br J Pharmacol; 1993 Jun; 109(2):424-9. PubMed ID: 8358543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of three adenosine receptor types.
    Gurden MF; Coates J; Ellis F; Evans B; Foster M; Hornby E; Kennedy I; Martin DP; Strong P; Vardey CJ
    Br J Pharmacol; 1993 Jul; 109(3):693-8. PubMed ID: 8358566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
    Martin PL; Ueeda M; Olsson RA
    J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxations of isolated rabbit coronary artery by purine derivatives: A2-adenosine receptors.
    Odawara S; Kurahashi K; Usui H; Taniguchi T; Fujiwara M
    J Cardiovasc Pharmacol; 1986; 8(3):567-73. PubMed ID: 2425175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 8-phenyl-substituted xanthine derivative is a selective antagonist at adenosine A1-receptors in vivo.
    Jakobson KA; Kirk KL; Daly JW; Jonzon B; Li YO; Fredholm BB
    Acta Physiol Scand; 1985 Oct; 125(2):341-2. PubMed ID: 3000136
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
    Merkel LA; Lappe RW; Rivera LM; Cox BF; Perrone MH
    J Pharmacol Exp Ther; 1992 Feb; 260(2):437-43. PubMed ID: 1310735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evidence for the presence of adenosine A2-receptors in cultured coronary endothelial cells.
    Des Rosiers C; Nees S
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):94-8. PubMed ID: 2819748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
    Ueeda M; Thompson RD; Arroyo LH; Olsson RA
    J Med Chem; 1991 Apr; 34(4):1340-4. PubMed ID: 2016708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of 2-phenylaminoadenosine (CV 1808) with adenosine systems in rat tissues.
    Taylor DA; Williams M
    Eur J Pharmacol; 1982 Dec; 85(3-4):335-8. PubMed ID: 6295788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular actions of adenosines, but not adenosine receptors, differ in rat and guinea pig.
    Ueeda M; Thompson RD; Padgett WL; Secunda S; Daly JW; Olsson RA
    Life Sci; 1991; 49(18):1351-8. PubMed ID: 1921650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adenosine and two stable adenosine analogues on blood pressure, heart rate and colonic temperature in the rat.
    Jonzon B; Bergquist A; Li YO; Fredholm BB
    Acta Physiol Scand; 1986 Apr; 126(4):491-8. PubMed ID: 3012948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilatory effects of adenosine A2 receptor agonists CGS 21680 and CGS 22492 in human vasculature.
    Makujina SR; Sabouni MH; Bhatia S; Douglas FL; Mustafa SJ
    Eur J Pharmacol; 1992 Oct; 221(2-3):243-7. PubMed ID: 1426003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.
    Ueeda M; Thompson RD; Arroyo LH; Olsson RA
    J Med Chem; 1991 Apr; 34(4):1334-9. PubMed ID: 2016707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo.
    Davies LP; Baird-Lambert J; Marwood JF
    Biochem Pharmacol; 1986 Sep; 35(18):3021-9. PubMed ID: 3019353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coronary endothelium: a highly active metabolic barrier for adenosine.
    Nees S; Herzog V; Becker BF; Böck M; Des Rosiers Ch; Gerlach E
    Basic Res Cardiol; 1985; 80(5):515-29. PubMed ID: 3000345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3',5'-monophosphate accumulation in rat and guinea-pig thymocytes.
    Fredholm BB; Sandberg G
    Br J Pharmacol; 1983 Dec; 80(4):639-44. PubMed ID: 6100843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive and renal vasodilator effects of carbocyclic adenosine (aristeromycin) in anesthetized spontaneously hypertensive rats.
    Dunham EW; Vince R
    J Pharmacol Exp Ther; 1986 Sep; 238(3):954-9. PubMed ID: 3018227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of enprofylline on A1 and A2 adenosine receptors.
    Ukena D; Schirren CG; Schwabe U
    Eur J Pharmacol; 1985 Oct; 117(1):25-33. PubMed ID: 3002801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.
    Alexander SP; Losinski A; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Jan; 111(1):185-90. PubMed ID: 8012695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.